Machine learning

#Artificial intelligence (AI) #Drug discovery #Funding #Ginkgo #Immunology / Virology & Vaccines #Machine learning #Vaccine adjuvants

Ginkgo Bioworks to discover and develop novel vaccine adjuvants 

A five-year contract totalling up to $31 million including programme options has been awarded to Ginkgo Bioworks to discover and develop next-generation vaccine adjuvants. The contract was awarded by the Defense Threat Reduction Agency’s (DTRA) Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense (CBD)… Read More

#News

2024 predictions, road forward
#2024 predictions #AI / data analytics / healthtech / informatics #Antiverse #Artificial intelligence (AI) #Drug discovery #Elsevier #Enhanc3D Genomics #IQVIA #Lab automation #Machine learning #Medidata #Ori Biotech #Technology #TrakCel #Trinity Life Sciences

2024 predictions: Experts comment on AI, ML and automation

DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. This is part of a series of predictions based on different themes. Here, experts weigh in on the impact of artificial intelligence (AI), machine learning (ML) and automation in… Read More

#Exclusive Content #Opinion #Trends & Analysis

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Digital solutions #Generative AI #Machine learning

Siloed use of Gen AI will limit its transformation potential

As long as drug discovery, development and commercialisation activities and budgets continue to be managed in isolation, and Generative AI projects applied in a piecemeal fashion to individual applications, the pharma industry risks inhibiting the technology’s broader potential. Daniel Jamieson, CEO & founder of Biorelate, sets out his… Read More

#Exclusive Content

Conference microphone
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Events #Machine learning #SLAS2024

SLAS2024 speaker news: How can AI maximise drug discovery?

The SLAS Ignite Theater ‘Innovation & technology: from lab to patient’ will take place at SLAS2024 in Boston on 5 and 6 February 2024. The event will be curated by DDW and sponsored by Integra Biosciences and Hamamatsu Corporation, providing leading research from… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Biosecurity #Federation of American Scientists #Machine learning

Federation of American Scientists addresses biosecurity risks of AI

The Federation of American Scientists (FAS) has published five policy recommendations to address the challenges of artificial intelligence (AI) in life sciences. The Bio X AI policy recommendations address the need for oversight of biodesign AI tools, biosecurity screening of synthetic DNA and guidance on biosecurity… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cloud computing #Drug discovery #Machine learning

Future-proofing drug discovery through flexible platforms

Dr Robert Scoffin, CEO, and Tim Cheeseright, Chief Technology Officer, at Cresset, explore the importance of flexible solutions for future-proofing drug discovery.  The ability to respond to changes in patient and customer needs is a constant challenge in the pharmaceutical industry, with ever-evolving requirements influencing even… Read More

#Exclusive Content

Lisbon skyline
#Bispecific Antibodies #Immunotherapy #Machine learning #PEGS Europe 2023 #Protein engineering

What to expect from PEGS Europe 2023: Day 3

Ahead of protein and antibody engineering conference PEGS Europe 2023 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. On Day 3, Thursday 16 November 2023, the tracks include: the second part of machine learning for protein engineering, antibodies against… Read More

#Exclusive Content

Lisbon skyline
#Biotherapeutics #CAR-T #Combination therapy #Drug targets #Engineered antibodies #Machine learning #PEGS Europe 2023

What to expect from PEGS Europe 2023: Day 2

Ahead of protein and antibody engineering conference PEGS Europe 2023 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. On Day 2, Wednesday 15 November 2023, the tracks include: Engineering antibodies, emerging targets and therapeutic approaches, advancing bispecifics and combination… Read More

#Exclusive Content

Machine learning concept
#Artificial intelligence (AI) #Drug discovery #Machine learning #VeriSIM Life

The impact of AI and ML on the future of drug discovery  

Over the past several years, Dr Jo Varshney, Founder of VeriSIM Life, has front-led numerous collaborative engagements with a host of biopharma companies, government agencies, academic/medical institutes and industry innovators. Here, she discusses with DDW’s Megan Thomas the impact of AI and ML on the drug discovery process.   MT:… Read More

#Exclusive Content #Opinion

#Artificial intelligence (AI) #BioIndustry Association #Machine learning #TechBio #UK

Five UK TechBio companies driving the AI revolution

The UK TechBio sector is thriving, according to a new report, with a growing number of companies pioneering ground-breaking products and services. A BioIndustry Association (BIA) report lists the widespread adoption of artificial intelligence (AI) and machine learning (ML), the advancement of gene editing technologies, the… Read More

#News #Trends & Analysis

#AI #Drug discovery #Generative AI #Machine learning

Generative AI and drug discovery: webinar

The webinar ‘Generative AI: Turning drug discovery into a technological pursuit’ supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President,… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trials #Imaging #Machine learning

Integration of AI in imaging clinical trials 

Sophie Winandy, Executive Director of Medical Imaging at ICON explores the benefits of AI and how it can be integrated throughout medical imaging within clinical trials.   Artificial intelligence (AI) is rapidly taking hold in the healthcare sector1, including in medical imaging, where AI often targets screening, patient eligibility,… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Clarivate #Machine learning

Seven AI drug discovery companies to watch

Seven companies have been highlighted in Clarivate’s ‘Companies to Watch Report’ for delivering more effective and safer medicines to market faster by leveraging artificial intelligence (AI) and machine learning (ML) technology. From identifying novel targets to simulating how drugs will function in the human body, Clarivate… Read More

#News #Trending News

AI concept
#AI #Generative AI #Machine learning #Webinar

Webinar: How AI is transforming drug discovery

This webinar supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President, Protein Sciences at Generate:Biomedicines who will discuss how an… Read More

#News

#AI #Drug discovery #Generative AI #Machine learning #Webinar

Generative AI webinar: Turning drug discovery into a technological pursuit

This webinar supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President, Protein Sciences at Generate:Biomedicines who will discuss how an… Read More

#News

Future lab, AI and digital data
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Lab automation #Machine learning #Webinar

AI & Lab Automation: What are the key benefits and latest innovations?

In this webinar, hosted by DDW and co-sponsored by Benchling and Proscia, you will learn about the key benefits and latest innovations to be aware of in AI and lab automation. You will hear from Jeremy Skillington, CEO of Poolbeg Pharma, as well as sponsor presentations from Helen Liu-Mayo, Product… Read More

Webinar date:
Co-sponsored by Benchling and Proscia
#Webinars